Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.68 |
| ▸ | LTA4H | P09960 | 1/20 | 0.60 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.60 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.60 |
| ▸ | MPO | P05164 | 8/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | HTR6 | P50406 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | HTR1D | P28221 | 1/20 | 0.46 |
| ▸ | HTR1B | P28222 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR7 | P34969 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23211671 | 0.82 | HTR6 (0.71) | HTR2ALTA4HPLA2G2ATRPM8MPO | |
| SCHEMBL1424902 | 0.81 | HTR2A (1.00) | HTR2ALTA4HPLA2G2ATRPM8MPO | |
| SCHEMBL21333273 | 0.80 | MPO (0.57) | HTR2ALTA4HPLA2G2ATRPM8MPO | |
| Hydrochloric Acid SCHEMBL7823519 | 0.79 | HTR2A (0.97) | HTR2ALTA4HPLA2G2ATRPM8MPO | |
| SCHEMBL14907351 | 0.78 | HTR2A (0.74) | HTR2ALTA4HPLA2G2ATRPM8MPO | |
| SCHEMBL14962766 | 0.77 | HTR2A (0.68) | HTR2ALTA4HPLA2G2ATRPM8MPO | |
| SCHEMBL15732779 | 0.77 | HTR2A (0.68) | HTR2ATRPM8MPOHTR6CYP1A2 | |
| SCHEMBL30579433 | 0.75 | LTA4H (1.00) | HTR2ALTA4HPLA2G2ATRPM8MPO | |
| SCHEMBL5167328 | 0.75 | LTA4H (1.00) | HTR2ALTA4HPLA2G2ATRPM8MPO | |
| SCHEMBL1460642 | 0.73 | MPO (0.70) | HTR2ALTA4HPLA2G2ATRPM8MPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595497-B2 | Processes for the production of tryptamines | COMPASS PATHFINDER LIMITED (GB) | 2026-04-07 | — | — | US | claimed |
| US-12595497-B2 | Processes for the production of tryptamines | COMPASS PATHFINDER LIMITED (GB) | 2026-04-07 | — | — | US | disclosed |
| US-20240084344-A1 | PROCESSES FOR THE PRODUCTION OF TRYPTAMINES | COMPASS PATHFINDER LIMITED (GB) | 2024-03-14 | — | — | US | disclosed |
| US-11661617-B2 | Processes for the production of tryptamines | COMPASS PATHFINDER LIMITED (GB) | 2023-05-30 | — | — | US | disclosed |
| US-11136293-B2 | Processes for the production of tryptamines | NEW ATLAS BIOTECHNOLOGIES LLC (US) | 2021-10-05 | — | — | US | disclosed |
| US-20210277433-A1 | PROCESSES FOR THE PRODUCTION OF TRYPTAMINES | HERCULES CAPITAL, INC. | 2021-09-09 | — | — | US | disclosed |
| US-20210108238-A1 | PROCESSES FOR THE PRODUCTION OF TRYPTAMINES | HERCULES CAPITAL, INC. | 2021-04-15 | — | — | US | disclosed |
| EP-3762498-A1 | PROCESSES FOR THE PRODUCTION OF TRYPTAMINES | New Atlas Biotechnologies LLC (US) | 2021-01-13 | — | — | EP | disclosed |
| CN-112105734-A | Method for producing tryptamine | 新图集生物技术有限责任公司 | 2020-12-18 | — | — | CN | disclosed |
| WO-2019173797-A1 | PROCESSES FOR THE PRODUCTION OF TRYPTAMINES | NEW ATLAS BIOTECHNOLOGIES LLC (US) | 2019-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595497-B2 | Processes for the production of tryptamines | INMT, TPH1, TPH2 | HTR2A 67/4885LTA4H 960/4885PLA2G2A 1919/4885 |
| US-11661617-B2 | Processes for the production of tryptamines | TPH1, TPH2, AANAT | HTR2A 38/4885LTA4H 876/4885PLA2G2A 341/4885 |
| US-20240084344-A1 | PROCESSES FOR THE PRODUCTION OF TRYPTAMINES | TPH1, TPH2, AANAT | HTR2A 38/4885LTA4H 876/4885PLA2G2A 341/4885 |
| US-11136293-B2 | Processes for the production of tryptamines | TPH1, TPH2, AANAT | HTR2A 38/4885LTA4H 876/4885PLA2G2A 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.